In the third session from the Platelet Reactivity Testing Round Table, the panel discuss treatment options for high-risk PCI patients. Among the many fascinating points discussed in this session are a number of key issues including:
TimeDiscussion Point
01'03
A review of types of procedures in peripheral intervention that require antiplatelet therapy
03'50
What does the antiplatelet therapy consist of in peripheral interventional cases?
08'00
Are we rational in how we are approaching the choice in terms of mono-therapy in PAD patients?
12'10
What is the evidence in PAD intervention in terms of the impact of clopidegrel response on the risk on negative outcomes?
15'00
Is there a relationship between size of the artery and thrombotic risk?
18'30
In terms of drug response, are there clear lessons from peripheral arterial intervention that can be taken from cardiology?
21'45
How common are major bleeding complications in peripheral arterial interventions?
24'05
Are we going to see more studies in different organ areas as we have seen in cardiology?
This round table discussion is intended for an international audience, specifically interventional cardiologists, interventional radiologists and aligned healthcare professional involved with antiplatelet therapy.
The Round Table Event was supported by Accumetrics.
Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives: